{"transactions":[{"id":1641250,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":94279,"kind":"person","name":"Ni Fang","position":1,"cik":"0001895910","reported_name":"Ni Fang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-15T17:45:43.000Z","date":"2024-02-14","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to this option shall vest and become exercisable on February 14, 2025, with the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":200000,"derivative":{"exercise_price":4.86,"expiration_date":"2034-02-13","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001415889-24-003971","document":"form4-02152024_100235.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895910/000141588924003971/form4-02152024_100235.xml","form_type":"4"}},{"id":2013814,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":94279,"kind":"person","name":"Ni Fang","position":1,"cik":"0001895910","reported_name":"Ni Fang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-15T16:11:48.000Z","date":"2023-02-13","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to this option shall vest and become exercisable on February 13, 2024, with the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":400000,"derivative":{"exercise_price":2.92,"expiration_date":"2033-02-12","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001104659-23-022389","document":"tm236831-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895910/000110465923022389/tm236831-5_4seq1.xml","form_type":"4"}},{"id":2076911,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":94279,"kind":"person","name":"Ni Fang","position":1,"cik":"0001895910","reported_name":"Ni Fang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2022-12-23T16:23:37.000Z","date":"2022-12-22","kind":"purchase","acquired":true,"shares":36363,"price":1.2814,"value":46595.5482,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.23 to $1.3099, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":125389,"source":{"system":"sec-edgar","filing":"0001415889-22-012966","document":"form4-12232022_091226.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1895910/000141588922012966/form4-12232022_091226.xml","form_type":"4"}},{"id":2076910,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":94279,"kind":"person","name":"Ni Fang","position":1,"cik":"0001895910","reported_name":"Ni Fang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2022-12-23T16:23:37.000Z","date":"2022-12-21","kind":"purchase","acquired":true,"shares":20000,"price":1.2885,"value":25770.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.27 to $1.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":89026,"source":{"system":"sec-edgar","filing":"0001415889-22-012966","document":"form4-12232022_091226.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895910/000141588922012966/form4-12232022_091226.xml","form_type":"4"}},{"id":2218800,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":94279,"kind":"person","name":"Ni Fang","position":1,"cik":"0001895910","reported_name":"Ni Fang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2022-06-30T16:05:33.000Z","date":"2022-06-29","kind":"purchase","acquired":true,"shares":25000,"price":2.4407,"value":61017.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.394 to $2.5599, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":69026,"source":{"system":"sec-edgar","filing":"0001415889-22-007099","document":"form4-06302022_010621.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895910/000141588922007099/form4-06302022_010621.xml","form_type":"4"}},{"id":2388927,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":94279,"kind":"person","name":"Ni Fang","position":1,"cik":"0001895910","reported_name":"Ni Fang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-17T16:15:51.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to this option shall vest and become exercisable on February 15, 2023, with the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":100000,"derivative":{"exercise_price":3.79,"expiration_date":"2032-02-14","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-22-001513","document":"form4-02172022_010232.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895910/000141588922001513/form4-02172022_010232.xml","form_type":"4"}}]}